Pancreatic Cancer Research

ResearcherIndiana University IndianapolisNo recent work listed

Lijun Cheng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6336-5416; OpenAlex author ID A5060412535. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2020: 2 papers · 2021: none · 2022: 1 paper

Papers 3

  1. Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint Therapy. First author DOI 10.1158/0008-5472.can-22-0018↗
  2. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma. Last author DOI 10.1186/s12920-020-0681-6↗
  3. Identification of Potential Serum Protein Biomarkers and Pathways for Pancreatic Cancer Cachexia Using an Aptamer-Based Discovery Platform. Co-author DOI 10.3390/cancers12123787↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaoqi Liu · 2 shared papers, 2020–2022 · strength 0.27
  2. Zhuangzhuang Zhang · 2 shared papers, 2020–2022 · strength 0.27
  3. Enze Liu · 1 shared paper, 2020 · strength 0.15
  4. Stephen F Konieczny · 1 shared paper, 2022 · strength 0.12
  5. Safi Shahda · 1 shared paper, 2020 · strength 0.11
  6. Ashok Narasimhan · 1 shared paper, 2020 · strength 0.11
  7. Joshua K. Kays · 1 shared paper, 2020 · strength 0.11
  8. Leonidas G. Koniaris · 1 shared paper, 2020 · strength 0.11
  9. Teresa A Zimmers · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.